Celldex Therapeutics buy Rouvenhey
Start price
26.02.20
/
50%
€2.27
Target price
04.11.21
€3.00
Performance (%)
566.52%
End price
05.11.20
€15.13
Summary
This prediction ended on 05.11.20 with a price of €15.13. With a performance of 566.52% the BUY prediction by Rouvenhey was a big success. Rouvenhey has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Celldex Therapeutics | -3.825% | -3.825% | 7.317% | 39.572% |
iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by Rouvenhey for this prediction
In the thread Celldex Therapeutics diskutieren
Buy mit Kursziel 3,0